Janet Dorling
Corporate Officer/Principal presso GILEAD SCIENCES, INC.
Posizioni attive di Janet Dorling
Società | Posizione | Inizio | Fine |
---|---|---|---|
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/05/2020 | - |
Gilead Sciences Belgium BV
Gilead Sciences Belgium BV Medical DistributorsDistribution Services Gilead Sciences Belgium BV is a Belgian company that was founded in 2006. The private company is based in Machelen, Belgium. The company provides a portal for healthcare professionals under the name Gilead Sciences. | Direttore/Membro del Consiglio | 01/02/2023 | - |
Storia della carriera di Janet Dorling
Precedenti posizioni note di Janet Dorling
Società | Posizione | Inizio | Fine |
---|---|---|---|
CYMABAY THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 05/04/2021 | 22/03/2024 |
CYMABAY THERAPEUTICS, INC. | Corporate Officer/Principal | 05/08/2019 | 01/12/2019 |
ACHAOGEN | Corporate Officer/Principal | 27/02/2017 | 30/06/2019 |
ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/2015 | 01/01/2017 |
Formazione di Janet Dorling
University of California, Berkeley | Masters Business Admin |
Duke University | Graduate Degree |
Haas School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Belgio | 2 |
Posizioni
Corporate Officer/Principal | 4 |
Masters Business Admin | 2 |
Director/Board Member | 2 |
Settori
Health Technology | 5 |
Consumer Services | 4 |
Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
ROCHE HOLDING AG | Health Technology |
Aziende private | 3 |
---|---|
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Gilead Sciences Belgium BV
Gilead Sciences Belgium BV Medical DistributorsDistribution Services Gilead Sciences Belgium BV is a Belgian company that was founded in 2006. The private company is based in Machelen, Belgium. The company provides a portal for healthcare professionals under the name Gilead Sciences. | Distribution Services |
- Borsa valori
- Insiders
- Janet Dorling
- Esperienza